Title:
hPPAR活性化剤
Document Type and Number:
Japanese Patent JP4383177
Kind Code:
B2
Abstract:
Compounds of formula (1) or a pharmaceutically acceptable salt, solvate, acid isostere, or hydrolyzable ester thereof, are disclosed. Methods of making and using the compounds are also disclosed. In particular methods for treating diseases or conditions associated with one or more of human PPAR alpha, gamma, or delta ("hPPARs") comprising administration of a therapeutically effective amount of a compound of formula (1), are disclosed
Inventors:
Cadilla, Rodolfo
Henke, Blood, Richard
Lambert, Millard, H. The Third
Riu, Guanchen, Kevin
Smith, jennifer, susan
Henke, Blood, Richard
Lambert, Millard, H. The Third
Riu, Guanchen, Kevin
Smith, jennifer, susan
Application Number:
JP2003572964A
Publication Date:
December 16, 2009
Filing Date:
February 25, 2003
Export Citation:
Assignee:
SmithKline Beechham Corporation
International Classes:
C07C279/08; C07D237/22; A61K31/192; A61K31/423; A61K31/4245; A61K31/426; A61K31/428; A61K31/44; A61K31/4402; A61K31/4406; A61K31/4409; A61K31/4439; A61K31/454; A61K31/50; A61K31/505; A61K31/506; A61K31/5377; A61P3/06; A61P3/10; A61P9/00; A61P9/02; A61P9/10; A61P17/00; A61P17/06; A61P29/00; A61P43/00; C07C215/52; C07C217/60; C07C335/12; C07D213/38; C07D213/55; C07D213/61; C07D213/74; C07D237/20; C07D239/42; C07D241/20; C07D261/20; C07D263/58; C07D271/06; C07D271/07; C07D275/02; C07D277/20; C07D277/42; C07D277/82; C07D401/12; C07D403/12; C07D405/04; C07D405/12; C07D409/04; C07D409/12; C07D413/04; C07D413/12; C07D413/14
Domestic Patent References:
| JP2005506379A | ||||
| JP2004513935A | ||||
| JP2002544254A |
Foreign References:
| WO1998017646A1 | ||||
| WO2002046176A1 |
Attorney, Agent or Firm:
Yusuke Hiraki
Ishii Teiji
Satoshi Fujita
Eiichi Arai
Ishii Teiji
Satoshi Fujita
Eiichi Arai